Literature DB >> 3144695

Molecular analysis of sodium butyrate-induced growth arrest.

A Toscani1, D R Soprano, K J Soprano.   

Abstract

Sodium butyrate has been shown to exert dramatic effects on the growth of cells in culture. It inhibits DNA synthesis, arrests actively proliferating cells in G1 and induces differentiation. The mechanism responsible for these various anti-proliferative effects is presently unknown. We wished to study the effects of sodium butyrate on cell growth at the molecular level, by analyzing the pattern of expression exhibited by several growth-associated genes (e.g., c-fos, c-myc, p53 and thymidine kinase) in Swiss 3T3 cells following treatment with sodium butyrate. Our results suggest that sodium butyrate-induced growth arrest of Swiss 3T3 cells (1) can be distinguished at a molecular level from the arrest brought about by other means of growth arrest; (2) does not result from a generalized mechanism which non-specifically shuts down the expression of growth-associated genes but rather occurs via a more specific mechanism which leads to the reduction in the expression of certain genes (e.g., c-myc, p53, thymidine kinase) while inducing the expression of others (e.g., c-fos, aP2); and (3) may involve one or more of the molecular events leading to adipocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3144695

Source DB:  PubMed          Journal:  Oncogene Res        ISSN: 0890-6467


  10 in total

1.  Involvement of Gialpha2 in sodium butyrate-induced erythroblastic differentiation of K562 cells.

Authors:  M G Davis; Y Kawai; I J Arinze
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

2.  Enhanced apoptosis in transformed human lung fibroblasts after exposure to sodium butyrate.

Authors:  G L Thomas; A Henley; T C Rowland; A Sahai; M Griffin; P J Birckbichler
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-09       Impact factor: 2.416

Review 3.  Butyrate and the colonocyte. Implications for neoplasia.

Authors:  O C Velázquez; H M Lederer; J L Rombeau
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

4.  n-Butyrate mediated inhibition of papovavirus DNA replication in vivo and in cell culture: a mechanistic approach.

Authors:  F F Shadan; L P Villarreal
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

5.  Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells.

Authors:  Y Zimra; L Wasserman; L Maron; M Shaklai; A Nudelman; A Rephaeli
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

6.  Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease.

Authors:  G F Atweh; M Sutton; I Nassif; V Boosalis; G J Dover; S Wallenstein; E Wright; L McMahon; G Stamatoyannopoulos; D V Faller; S P Perrine
Journal:  Blood       Date:  1999-03-15       Impact factor: 22.113

Review 7.  Short-chain acyl-CoA dehydrogenase deficiency: from gene to cell pathology and possible disease mechanisms.

Authors:  Zahra Nochi; Rikke Katrine Jentoft Olsen; Niels Gregersen
Journal:  J Inherit Metab Dis       Date:  2017-05-17       Impact factor: 4.982

Review 8.  Review of harmful gastrointestinal effects of carrageenan in animal experiments.

Authors:  J K Tobacman
Journal:  Environ Health Perspect       Date:  2001-10       Impact factor: 9.031

9.  A study protocol to investigate the relationship between dietary fibre intake and fermentation, colon cell turnover, global protein acetylation and early carcinogenesis: the FACT study.

Authors:  Bernard M Corfe; Elizabeth A Williams; Jonathan P Bury; Stuart A Riley; Lisa J Croucher; Daphne Y L Lai; Caroline A Evans
Journal:  BMC Cancer       Date:  2009-09-18       Impact factor: 4.430

10.  Differentiation-dependent photodynamic therapy regulated by porphobilinogen deaminase in B16 melanoma.

Authors:  D Ickowicz Schwartz; Y Gozlan; L Greenbaum; T Babushkina; D J Katcoff; Z Malik
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.